Literature DB >> 18350273

Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases.

Anna Vilalta1, Juan Sahuquillo, Anna Rosell, Maria A Poca, Marilyn Riveiro, Joan Montaner.   

Abstract

OBJECTIVE: Recent experimental evidence suggests that matrix metalloproteinases (MMPs) are implicated in the pathophysiology of traumatic brain injury (TBI) by increasing blood-brain barrier permeability and exacerbating posttraumatic edema. We examined the acute profile of MMP-2 and MMP-9 in the plasma of patients with moderate or severe TBI and in the brain extracellular fluid (ECF).
DESIGN: Prospective observational study.
SETTING: Neurotraumatology intensive care unit of a tertiary university hospital. PATIENTS: Twenty patients with moderate or severe TBI were included and three groups were used as controls: 20 patients with a mild head injury and normal CT scan, 15 moderate polytrauma patients without TBI, and 20 healthy volunteers.
INTERVENTIONS: Plasma samples were collected within the first 12[Symbol: see text]h and at 24[Symbol: see text]h post-injury. Simultaneous brain microdialysate and plasma samples were obtained in four moderate-severe TBI patients at additional timepoints: 48, 72, and 96[Symbol: see text]h post-TBI.
MEASUREMENTS AND MAIN RESULTS: Gelatinases (MMP-2 and MMP-9) were measured by gelatin zymography. A significant increase in plasma gelatinases was observed at baseline when compared with healthy volunteers in the study group. This early increase was followed by a significant decrease at 24[Symbol: see text]h post-injury. Brain microdialysis samples presented a similar time profile as plasma samples for both gelatinases.
CONCLUSIONS: High levels of gelatinases were found in plasma and brain ECF in the early phase of TBI, indicating that both local and systemic trauma-induced upregulation of gelatinases in the acute phase might play an important role in the pathophysiology of TBI and could be a future therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350273     DOI: 10.1007/s00134-008-1056-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

1.  Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury.

Authors:  X Wang; J Jung; M Asahi; W Chwang; L Russo; M A Moskowitz; C E Dixon; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

2.  Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo.

Authors:  G G Vecil; P H Larsen; S M Corley; L M Herx; A Besson; C G Goodyer; V W Yong
Journal:  J Neurosci Res       Date:  2000-07-15       Impact factor: 4.164

3.  Percutaneous implantation of cerebral microdialysis catheters by twist-drill craniostomy in neurocritical patients: description of the technique and results of a feasibility study in 97 patients.

Authors:  Maria A Poca; Juan Sahuquillo; Anna Vilalta; Jorge de los Rios; Angel Robles; Lourdes Exposito
Journal:  J Neurotrauma       Date:  2006-10       Impact factor: 5.269

Review 4.  Current aspects of pathophysiology and cell dysfunction after severe head injury.

Authors:  J Sahuquillo; M A Poca; S Amoros
Journal:  Curr Pharm Des       Date:  2001-10       Impact factor: 3.116

5.  Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats.

Authors:  Y Shigemori; Y Katayama; T Mori; T Maeda; T Kawamata
Journal:  Acta Neurochir Suppl       Date:  2006

6.  Increases in matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 mRNA after cerebral contusion and depolarisation.

Authors:  Christina von Gertten; Staffan Holmin; Tiit Mathiesen; Ann-Christin Sandberg Nordqvist
Journal:  J Neurosci Res       Date:  2003-09-15       Impact factor: 4.164

7.  Gelatinase B modulates selective opening of the blood-brain barrier during inflammation.

Authors:  S Mun-Bryce; G A Rosenberg
Journal:  Am J Physiol       Date:  1998-05

Review 8.  Matrix metalloproteinases in brain injury.

Authors:  G A Rosenberg
Journal:  J Neurotrauma       Date:  1995-10       Impact factor: 5.269

9.  Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

Authors:  Joan Montaner; Carlos A Molina; Jasone Monasterio; Sonia Abilleira; Juan F Arenillas; Marc Ribó; Manolo Quintana; José Alvarez-Sabín
Journal:  Circulation       Date:  2003-02-04       Impact factor: 29.690

Review 10.  Chemokines and matrix metalloproteinase-9 in leukocyte recruitment to the central nervous system.

Authors:  F Sellebjerg; T L Sørensen
Journal:  Brain Res Bull       Date:  2003-08-15       Impact factor: 4.077

View more
  29 in total

1.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

2.  [Influence of massive blood transfusion and traumatic brain injury on TIMP‑1 and MMP‑9 serum levels in polytraumatized patients].

Authors:  M Braunstein; T Kusmenkov; W Böcker; V Bogner-Flatz
Journal:  Unfallchirurg       Date:  2019-12       Impact factor: 1.000

Review 3.  How to Translate Time: The Temporal Aspects of Rodent and Human Pathobiological Processes in Traumatic Brain Injury.

Authors:  Denes V Agoston; Robert Vink; Adel Helmy; Mårten Risling; David Nelson; Mayumi Prins
Journal:  J Neurotrauma       Date:  2019-03-07       Impact factor: 5.269

4.  Impact of moderate blast exposures on thrombin biomarkers assessed by calibrated automated thrombography in rats.

Authors:  Victor Prima; Victor L Serebruany; Artem Svetlov; Ronald L Hayes; Stanislav I Svetlov
Journal:  J Neurotrauma       Date:  2013-10-04       Impact factor: 5.269

5.  Sulfonylurea Receptor 1 in Humans with Post-Traumatic Brain Contusions.

Authors:  Tamara Martínez-Valverde; Marian Vidal-Jorge; Elena Martínez-Saez; Lidia Castro; Fuat Arikan; Esteban Cordero; Andreea Rădoi; Maria-Antonia Poca; J Marc Simard; Juan Sahuquillo
Journal:  J Neurotrauma       Date:  2015-06-03       Impact factor: 5.269

6.  Associations of markers of inflammation and coagulation with delirium during critical illness.

Authors:  Timothy D Girard; Lorraine B Ware; Gordon R Bernard; Pratik P Pandharipande; Jennifer L Thompson; Ayumi K Shintani; James C Jackson; Robert S Dittus; E Wesley Ely
Journal:  Intensive Care Med       Date:  2012-08-18       Impact factor: 17.440

7.  Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury.

Authors:  Mark Grossetete; Jeremy Phelps; Leopold Arko; Howard Yonas; Gary A Rosenberg
Journal:  Neurosurgery       Date:  2009-10       Impact factor: 4.654

8.  The potential utility of blood-derived biochemical markers as indicators of early clinical trends following severe traumatic brain injury.

Authors:  Michael V DeFazio; Richard A Rammo; Jaime R Robles; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  World Neurosurg       Date:  2013-01-08       Impact factor: 2.104

9.  Inhibition of Myosin light-chain kinase attenuates cerebral edema after traumatic brain injury in postnatal mice.

Authors:  Janet L Rossi; Tracey Todd; Nicolas G Bazan; Ludmila Belayev
Journal:  J Neurotrauma       Date:  2013-08-28       Impact factor: 5.269

10.  The 70 kDa heat shock protein protects against experimental traumatic brain injury.

Authors:  Jong Youl Kim; Nuri Kim; Zhen Zheng; Jong Eun Lee; Midori A Yenari
Journal:  Neurobiol Dis       Date:  2013-06-29       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.